Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance

por Chang, Jenny C.
Publicado 2016

The promise of microarrays in the management and treatment of breast cancer

por Chang, Jenny C, Hilsenbeck, Susan G, Fuqua, Suzanne AW
Publicado 2005

Cancer stem cells: A nuanced perspective

por Rich, Jeremy N., Matsui, William H., Chang, Jenny C.
Publicado 2016

Epithelial-mesenchymal transition, cancer stem cells and treatment resistance

por Dave, Bhuvanesh, Mittal, Vivek, Tan, Nicholas M, Chang, Jenny C
Publicado 2012

Patient-derived breast tumor xenografts facilitating personalized cancer therapy

por Landis, Melissa D, Lehmann, Brian D, Pietenpol, Jennifer A, Chang, Jenny C
Publicado 2013

Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers

por Morrison, Chevaun D, Chang, Jenny C, Keri, Ruth A, Schiemann, William P
Publicado 2017

Utility of Cell-Free DNA Detection in Transplant Oncology

por Reddy, Tejaswini, Esmail, Abdullah, Chang, Jenny C., Ghobrial, Rafik Mark, Abdelrahim, Maen
Publicado 2022

A comparative efficacy study of diagnostic digital breast tomosynthesis and digital mammography in BI-RADS 4 breast cancer diagnosis

por Ezeana, Chika F., Puppala, Mamta, Wang, Lin, Chang, Jenny C., Wong, Stephen T.C.
Publicado 2022

Targeting Nitric Oxide: Say NO to Metastasis

por Reddy, Tejaswini P., Glynn, Sharon A., Billiar, Timothy R., Wink, David A., Chang, Jenny C.
Publicado 2023

A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations

por Reddy, Tejaswini P., Rosato, Roberto R., Li, Xiaoxian, Moulder, Stacy, Piwnica-Worms, Helen, Chang, Jenny C.
Publicado 2020

Erratum to: Dual HER2 blockade: preclinical and clinical data

por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado 2014

Dual HER2 blockade: preclinical and clinical data

por Patel, Tejal A, Dave, Bhuvanesh, Rodriguez, Angel A, Chang, Jenny C, Perez, Edith A, Colon-Otero, Gerardo
Publicado 2014

Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression

por La Belle Flynn, Alyssa, Calhoun, Benjamin C., Sharma, Arishya, Chang, Jenny C., Almasan, Alexandru, Schiemann, William P.
Publicado 2019

The lncRNA BORG Drives Breast Cancer Metastasis and Disease Recurrence

por Gooding, Alex J., Zhang, Bing, Jahanbani, Fereshteh Kenari, Gilmore, Hannah L., Chang, Jenny C., Valadkhan, Saba, Schiemann, William P.
Publicado 2017

Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells

por Tanei, Tomonori, Choi, Dong Soon, Rodriguez, Angel A., Liang, Diana Hwang, Dobrolecki, Lacey, Ghosh, Madhumita, Landis, Melissa D., Chang, Jenny C.
Publicado 2016

c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression

por Morrison, Chevaun D., Allington, Tressa M., Thompson, Cheryl L., Gilmore, Hannah L., Chang, Jenny C., Keri, Ruth A., Schiemann, William P.
Publicado 2016

SNX27–retromer assembly recycles MT1-MMP to invadopodia and promotes breast cancer metastasis

por Sharma, Priyanka, Parveen, Sameena, Shah, Lekha V., Mukherjee, Madhumita, Kalaidzidis, Yannis, Kozielski, Anthony J., Rosato, Roberto, Chang, Jenny C., Datta, Sunando
Publicado 2019

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models

por Rosato, Roberto R., Dávila-González, Daniel, Choi, Dong Soon, Qian, Wei, Chen, Wen, Kozielski, Anthony J., Wong, Helen, Dave, Bhuvanesh, Chang, Jenny C.
Publicado 2018

Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs

por Reddy, Tejaswini P., Choi, Dong S., Anselme, Ann C., Qian, Wei, Chen, Wen, Lantto, Johan, Horak, Ivan D., Kragh, Michael, Chang, Jenny C., Rosato, Roberto R.
Publicado 2020

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6

por Chung, Andrew W., Kozielski, Anthony J., Qian, Wei, Zhou, Jianying, Anselme, Ann C., Chan, Alfred A., Pan, Ping-Ying, Lee, Delphine J., Chang, Jenny C.
Publicado 2022